Main > NEUROLOGY. > Multiple Sclerosis > Treatment > AlemtuzuMAb (Anti CD52 MAb) > Co.: USA. G. (Phase III/Patent)

---

Co.: USA. G. (Phase III/Patent)'s subsections
Company
Patent>Assignee; Claims; No.; Etc.
TradeMark
Web-Site (PR>2011. 04.14.2011)

Co.: USA. G. (Phase III/Patent)'s products
This section has no products